SPY380.36-1.97 -0.52%
DIA309.45-4.53 -1.44%
IXIC13,192.35+72.96 0.56%

BRIEF-Roche Says FDA Grants Breakthrough Device Designation To Elecsys GDF-15 Assay

· 02/08/2021 01:07
BRIEF-Roche Says FDA Grants Breakthrough Device Designation To Elecsys GDF-15 Assay

- Roche Holding AG ROG.S:

  • FDA GRANTS BREAKTHROUGH DEVICE DESIGNATION FOR ROCHE'S ELECSYS GROWTH DIFFERENTIATION FACTOR-15 (GDF-15) ASSAY TO HELP IDENTIFY PATIENTS SUITABLE FOR INNOVATIVE TREATMENT ADDRESSING UNINTENTIONAL WEIGHT LOSS IN CANCER PATIENTS

Source text for Eikon: ID:nNDL2tysLq

Further company coverage: ROG.S


(Berlin Speed Desk)

((frankfurt.newsroom@thomsonreuters.com;))